Friday, March 22, 2024 12:11:33 AM
Pay attention to what Shawn Leon said in July 2023, "..."I have been questioned often about what our plans are to consolidate the stock and I can report that there are no near term plans to do so. I can only see that happening in conjunction with an up-listing when that time comes, and I believe it will come,..." Now the statement in the February 6th 2024 press release about "...financing and up-listing in the coming weeks... Now when Glacial Shawn mentions something to be done in weeks just say months, many months. 🤣
It takes FOREVER for Shawn Leon to do anything once he announces it but time must be running out because he has packed the debt right back on after the refinance fiasco. How bad it is should come with the annual which should be release in the next couple of weeks. My scenario for what he is going to eventually do in post# 49524. I believe that this will be trading at $0.0001 when he finally announced the plan and after the reverse split but it won't be the bottom because this will get hammered post split by the regulation "A" offering whos shares will be immediately tradable.
Bubae
Re: N-13 post# 49520
Wednesday, January 10, 2024 2:23:58 PM
Post# 49524 of 49781
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173601160
So I am looking for a 1:2400 reverse split because once announced you can bet it will be trading at $0.0001 in a flash. No one will want to hold these shares into a split knowing that it is a setup for the offering. This is why you should do the split first in my opinion. 🙄 So I'm thinking 1: 2400 gets the new price to $0.24 then sell the units, or really shares, priced at $0.12 for the discount to market. This will also fit Shawn Leon's narrative of an uplist effort in the event of a reverse split. He will need to maintain a trading price above a penny for that to have a chance.
Ethema Executes Two Real Estate Transactions and Major Debt Repayment
July 17, 2023 09:34 ET
https://www.globenewswire.com/en/news-release/2023/07/17/2705721/0/en/Ethema-Executes-Two-Real-Estate-Transactions-and-Major-Debt-Repayment.html
Ethema to Present an Update at the Emerging Growth Conference on February 8, 2024
February 06, 2024 08:00 ET
https://www.globenewswire.com/en/news-release/2024/02/06/2824259/0/en/Ethema-to-Present-an-Update-at-the-Emerging-Growth-Conference-on-February-8-2024.html
At these meetings, there was unanimous support for the Company’s growth plans supported by financing and up-listing. The Company hopes to identify which partners it will go forward with for the financing and up-listing in the coming weeks.
The SEC is widening its war on toxic funders
Published on August 24, 2021
https://www.linkedin.com/pulse/sec-widening-its-war-toxic-funders-steve-taylor/
...it also increasingly utilized qualified Reg A offerings to acquire free-trading stock which they then dumped into the market without disclosure....
..This was a significant concern, as Reg A shares are immediately free-trading...
...To make money on their toxic convertible loan, these funders require volume to dump into. Lots of volume, because they have a lot of stock to sell....
Everything that I post is just my informed opinion and is simply an invitation to debate. Trade on your own due diligence please..
Recent GRST News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 09:45:09 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:54:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/22/2023 09:04:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:55:26 PM
- Form 1-A POS - • Edgar (US Regulatory) • 10/20/2023 07:29:40 PM
- Form 1-A POS - • Edgar (US Regulatory) • 08/29/2023 07:21:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:37:36 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 12:43:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 04:51:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2023 06:56:41 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM